Optimal scheduling of drug treatment for HIV infection: Continuous dose control and receding horizon control

International Journal of Control, Automation and Systems

Volumn 1, Issue 3, 2003, Pages 282-288

  Shim, Hyungbo ^a   Han, Seung Ju ^b   Chung, Chung Choo ^a   Nam, Sang Won ^a   Seo, Jin Heon ^b  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Chemotherapy; HIV; Optimal control; Receding horizon control

Indexed keywords

BLOOD; CELLS; CHEMOTHERAPY; FEEDBACK; OPTIMAL CONTROL SYSTEMS; PATIENT MONITORING; SCHEDULING; VIRUSES;

HUMAN BODY; HUMAN IMMUNODEFICIENCY VIRUS (HIV); IMMUNE SYSTEM; RECEDING HORIZON CONTROL;

DRUG THERAPY;

EID: 4544281118     PISSN: 15986446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. H. K. Altes, D. A. Price, and V. A. Jansen, "Effector cytotoxic T lymphocyte numbers induced by vaccination should exceed levels in chronic infection for protection from HIV," Vaccine, vol. 20, pp. 3-6, 2002.
2. M. E. Brandt and G. Chen, "Feedback control of a biodynamical model of HIV-1," IEEE Trans. on Biomedical Engineering, vol. 48, no. 7, pp. 754-759, 2001.
3. A. E. Bryson, Dynamic Optimization, Addison Wesley Longman, Inc., 1999.
4. J. A. M. Felippe de Souza, M. A. L. Caetano, and T. Yoneyama, "Optimal control theory applied to the anti-viral treatment of AIDS," Proc. of Conference on Decision and Control, Sydney, 2000.
5. G. Grimm, M. J. Messina, A. R. Teel, and S. Tuna, "Model predictive control when a local control Lyapunov function is not available," Proc. of American Control Conference, 2003.
6. D. Kirschner, S. Lenhart, and S. Serbin, "Optimal control of the chemotherapy of HIV," J. of Mathematical Biology, vol. 35, pp. 775-792, 1997.
7. S. Kubiak, H. Lehr, R. Levy, T. Moeller, A. Parker, and E. Swim, "Modeling control of HIV infection through structured treatment interruptions with recommendations for experimental protocol," CRSC Technical Report (CRSCTR01-27), 2001. (Also at http://www.math.montana.edu/ ~parker.)
8. J. J. Kutch and P. Gurfil, "Optimal control of HIV infection with a continuously-mutating viral population," Proc. of American Control Conference, pp. 4033-4038, 2002.
9. U. Ledzewicz and H. Schattler, "On optimal controls for a general mathematical model for chemotherapy of HIV," Proc. of American Control Conference, pp. 3454-3459, 2002.
10. D. Mayne, J. B. Rawlings, C. V. Rao, and P. Scokaert, "Constrained model predictive control: stability and optimality," Automatica, vol. 36, pp. 789-814, 2000.
11. M. A. Nowak and R. M. May, Virus Dynamics, Oxford University Press Inc., New York, 2000.
12. On-line documents at http://www.cdc.gov/hiv, Divisions of HIV/AIDS Prevention, Centers for Disease Control and Prevention.
13. H. Ortega and M. Martin-Landrove, "A model for continuously mutant HIV-1," Proc. of 22nd Annual EMBS International Conference, pp. 1917-1920, Chicago, 2000.
14. A. S. Perelson and P. W. Nelson, "Mathematical analysis of HIV-1 dynamics in vivo," SIAM Review, vol. 41, no. 1, pp. 3-44, 1999.
15. A. Schwartz, "Theory and implementation of numerical methods based on Runge-Kutta integration for solving optimal control problems, Ph.D Dissertation, Univ. of California, Berkeley, 1996.
16. R. F. Stengel, R. Ghigliazza, N. Kulkarni, and O. Laplace, "Optimal control of a viral disease," Proc. of American Control Conference, pp. 3795-3800, 2001.
17. L. M. Wein, S. A. Zenios, and M. A. Nowak, "Dynamic multidrug therapies for HIV: A control theoretic approach," J. of Theoretical Biology, vol. 185, pp. 15-29, 1997.
18. D. Wodarz and M. A. Nowak, "Specific therapy regimes could lead to long-term immunological control of HIV," Proc. of National Academy Science, vol. 96, no. 25, pp. 14464-14469, 1999.
19. D. Wodarz, "Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance," J. of Theoretical Biology, vol. 213, pp. 447-459, 2001.
20. D. Wodarz and M. A. Nowak, "Mathematical models of HIV pathogenesis and treatment," BioEssays, vol. 24, pp. 1178-1187, Wiley Periodicals, 2002.
21. R. Zurakowski and A. R. Teel, "Enhancing immune response to HIV infection using MPC-based treatment scheduling," Proc. of American Control Conference, Denver, 2003.